NCT03433365View on ClinicalTrials.gov

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD)

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

August 31, 2017

Conditions
Multiple Myeloma
Interventions
OTHER

MRD analysis

To collect 2 samples for MRD analysis in patients treated with Lenalidomide

Trial Locations (1)

10126

AOU Città della Salute e della Scienza di Torino, Torino

All Listed Sponsors
lead

Fondazione EMN Italy Onlus

OTHER

NCT03433365 - Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD) | Biotech Hunter | Biotech Hunter